CN102784302A - 一种治疗肾阴亏虚型失眠的中药制备方法 - Google Patents
一种治疗肾阴亏虚型失眠的中药制备方法 Download PDFInfo
- Publication number
- CN102784302A CN102784302A CN201210270923XA CN201210270923A CN102784302A CN 102784302 A CN102784302 A CN 102784302A CN 201210270923X A CN201210270923X A CN 201210270923XA CN 201210270923 A CN201210270923 A CN 201210270923A CN 102784302 A CN102784302 A CN 102784302A
- Authority
- CN
- China
- Prior art keywords
- grams
- kidney
- traditional chinese
- deficiency
- chinese medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 title claims abstract description 26
- 206010022437 insomnia Diseases 0.000 title claims abstract description 26
- 239000003814 drug Substances 0.000 title claims abstract description 24
- 210000003734 kidney Anatomy 0.000 title abstract description 35
- 230000007812 deficiency Effects 0.000 title abstract description 11
- 238000000034 method Methods 0.000 title abstract description 5
- 238000011282 treatment Methods 0.000 claims abstract description 18
- 241000628997 Flos Species 0.000 claims abstract description 7
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims abstract description 7
- 239000007788 liquid Substances 0.000 claims abstract description 7
- 238000002360 preparation method Methods 0.000 claims abstract description 7
- 210000000582 semen Anatomy 0.000 claims description 18
- 208000031971 Yin Deficiency Diseases 0.000 claims description 17
- 229940079593 drug Drugs 0.000 claims description 11
- 241001450685 Corallium japonicum Species 0.000 claims description 6
- 239000000796 flavoring agent Substances 0.000 claims description 6
- 235000019634 flavors Nutrition 0.000 claims description 6
- 239000003643 water by type Substances 0.000 claims description 3
- 230000000694 effects Effects 0.000 abstract description 10
- 230000008901 benefit Effects 0.000 abstract description 4
- 231100000331 toxic Toxicity 0.000 abstract description 3
- 230000002588 toxic effect Effects 0.000 abstract description 3
- 239000000935 antidepressant agent Substances 0.000 abstract description 2
- 239000002249 anxiolytic agent Substances 0.000 abstract description 2
- 230000004799 sedative–hypnotic effect Effects 0.000 abstract description 2
- 235000013399 edible fruits Nutrition 0.000 abstract 2
- 244000003416 Asparagus officinalis Species 0.000 abstract 1
- 235000005340 Asparagus officinalis Nutrition 0.000 abstract 1
- 240000007124 Brassica oleracea Species 0.000 abstract 1
- 235000003899 Brassica oleracea var acephala Nutrition 0.000 abstract 1
- 235000011301 Brassica oleracea var capitata Nutrition 0.000 abstract 1
- 235000001169 Brassica oleracea var oleracea Nutrition 0.000 abstract 1
- 235000014653 Carica parviflora Nutrition 0.000 abstract 1
- 244000132059 Carica parviflora Species 0.000 abstract 1
- 241001107116 Castanospermum australe Species 0.000 abstract 1
- 241000218645 Cedrus Species 0.000 abstract 1
- 241000146384 Glaux Species 0.000 abstract 1
- 240000004670 Glycyrrhiza echinata Species 0.000 abstract 1
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 abstract 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 abstract 1
- 244000241838 Lycium barbarum Species 0.000 abstract 1
- 235000015459 Lycium barbarum Nutrition 0.000 abstract 1
- 235000015463 Lycium carolinianum Nutrition 0.000 abstract 1
- 240000000249 Morus alba Species 0.000 abstract 1
- 235000008708 Morus alba Nutrition 0.000 abstract 1
- 241000756042 Polygonatum Species 0.000 abstract 1
- 235000008737 Polygonatum biflorum Nutrition 0.000 abstract 1
- 235000002226 Ranunculus ficaria Nutrition 0.000 abstract 1
- 244000081426 Ranunculus ficaria Species 0.000 abstract 1
- 241000270666 Testudines Species 0.000 abstract 1
- 241000270708 Testudinidae Species 0.000 abstract 1
- 230000002411 adverse Effects 0.000 abstract 1
- 230000000949 anxiolytic effect Effects 0.000 abstract 1
- 235000021279 black bean Nutrition 0.000 abstract 1
- 235000007215 black sesame Nutrition 0.000 abstract 1
- 230000007547 defect Effects 0.000 abstract 1
- 229940010454 licorice Drugs 0.000 abstract 1
- 229940126680 traditional chinese medicines Drugs 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
- 210000004185 liver Anatomy 0.000 description 20
- 235000009508 confectionery Nutrition 0.000 description 19
- 210000002216 heart Anatomy 0.000 description 19
- 210000000952 spleen Anatomy 0.000 description 12
- 210000004072 lung Anatomy 0.000 description 10
- 210000002784 stomach Anatomy 0.000 description 10
- 208000002193 Pain Diseases 0.000 description 7
- 206010030113 Oedema Diseases 0.000 description 6
- 239000008280 blood Substances 0.000 description 6
- 210000004369 blood Anatomy 0.000 description 6
- 230000002936 tranquilizing effect Effects 0.000 description 6
- 241000201295 Euphrasia Species 0.000 description 5
- 206010010774 Constipation Diseases 0.000 description 4
- 206010012335 Dependence Diseases 0.000 description 4
- 206010062717 Increased upper airway secretion Diseases 0.000 description 4
- 206010041349 Somnolence Diseases 0.000 description 4
- 208000002173 dizziness Diseases 0.000 description 4
- 210000005036 nerve Anatomy 0.000 description 4
- 208000026435 phlegm Diseases 0.000 description 4
- 231100000614 poison Toxicity 0.000 description 4
- 206010019233 Headaches Diseases 0.000 description 3
- 241000475481 Nebula Species 0.000 description 3
- 230000003213 activating effect Effects 0.000 description 3
- 230000000954 anitussive effect Effects 0.000 description 3
- 229940124584 antitussives Drugs 0.000 description 3
- 230000000740 bleeding effect Effects 0.000 description 3
- PCHPORCSPXIHLZ-UHFFFAOYSA-N diphenhydramine hydrochloride Chemical compound [Cl-].C=1C=CC=CC=1C(OCC[NH+](C)C)C1=CC=CC=C1 PCHPORCSPXIHLZ-UHFFFAOYSA-N 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 231100000869 headache Toxicity 0.000 description 3
- 231100000862 numbness Toxicity 0.000 description 3
- 230000001717 pathogenic effect Effects 0.000 description 3
- 231100000572 poisoning Toxicity 0.000 description 3
- 230000000607 poisoning effect Effects 0.000 description 3
- 238000010926 purge Methods 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 208000011580 syndromic disease Diseases 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 2
- 208000010412 Glaucoma Diseases 0.000 description 2
- 206010020751 Hypersensitivity Diseases 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 208000005392 Spasm Diseases 0.000 description 2
- 208000026935 allergic disease Diseases 0.000 description 2
- 230000007815 allergy Effects 0.000 description 2
- 208000010668 atopic eczema Diseases 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000003014 reinforcing effect Effects 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 230000001502 supplementing effect Effects 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 230000001457 vasomotor Effects 0.000 description 2
- 210000003462 vein Anatomy 0.000 description 2
- 230000004304 visual acuity Effects 0.000 description 2
- 239000011800 void material Substances 0.000 description 2
- XQJMXPAEFMWDOZ-UHFFFAOYSA-N 3exo-benzoyloxy-tropane Natural products CN1C(C2)CCC1CC2OC(=O)C1=CC=CC=C1 XQJMXPAEFMWDOZ-UHFFFAOYSA-N 0.000 description 1
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 208000007848 Alcoholism Diseases 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- JZUFKLXOESDKRF-UHFFFAOYSA-N Chlorothiazide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC2=C1NCNS2(=O)=O JZUFKLXOESDKRF-UHFFFAOYSA-N 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 206010052804 Drug tolerance Diseases 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- JMBQKKAJIKAWKF-UHFFFAOYSA-N Glutethimide Chemical compound C=1C=CC=CC=1C1(CC)CCC(=O)NC1=O JMBQKKAJIKAWKF-UHFFFAOYSA-N 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical class OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- JEYCTXHKTXCGPB-UHFFFAOYSA-N Methaqualone Chemical compound CC1=CC=CC=C1N1C(=O)C2=CC=CC=C2N=C1C JEYCTXHKTXCGPB-UHFFFAOYSA-N 0.000 description 1
- SIDLZWOQUZRBRU-UHFFFAOYSA-N Methyprylon Chemical compound CCC1(CC)C(=O)NCC(C)C1=O SIDLZWOQUZRBRU-UHFFFAOYSA-N 0.000 description 1
- QQXLDOJGLXJCSE-UHFFFAOYSA-N N-methylnortropinone Natural products C1C(=O)CC2CCC1N2C QQXLDOJGLXJCSE-UHFFFAOYSA-N 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- QIZDQFOVGFDBKW-DHBOJHSNSA-N Pseudotropine Natural products OC1C[C@@H]2[N+](C)[C@H](C1)CC2 QIZDQFOVGFDBKW-DHBOJHSNSA-N 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 208000007107 Stomach Ulcer Diseases 0.000 description 1
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 1
- 206010043376 Tetanus Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 229940125713 antianxiety drug Drugs 0.000 description 1
- 229940005513 antidepressants Drugs 0.000 description 1
- 239000003212 astringent agent Substances 0.000 description 1
- 229940125717 barbiturate Drugs 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 229940006460 bromide ion Drugs 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- RNFNDJAIBTYOQL-UHFFFAOYSA-N chloral hydrate Chemical compound OC(O)C(Cl)(Cl)Cl RNFNDJAIBTYOQL-UHFFFAOYSA-N 0.000 description 1
- 229960002327 chloral hydrate Drugs 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- AAOVKJBEBIDNHE-UHFFFAOYSA-N diazepam Chemical compound N=1CC(=O)N(C)C2=CC=C(Cl)C=C2C=1C1=CC=CC=C1 AAOVKJBEBIDNHE-UHFFFAOYSA-N 0.000 description 1
- 229960003529 diazepam Drugs 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000009429 distress Effects 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- GXRZIMHKGDIBEW-UHFFFAOYSA-N ethinamate Chemical compound NC(=O)OC1(C#C)CCCCC1 GXRZIMHKGDIBEW-UHFFFAOYSA-N 0.000 description 1
- 229960002209 ethinamate Drugs 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 201000005917 gastric ulcer Diseases 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 229960002972 glutethimide Drugs 0.000 description 1
- 230000026781 habituation Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 229960002003 hydrochlorothiazide Drugs 0.000 description 1
- 230000000147 hypnotic effect Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 238000010255 intramuscular injection Methods 0.000 description 1
- 239000007927 intramuscular injection Substances 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 229960002803 methaqualone Drugs 0.000 description 1
- 229960000316 methyprylon Drugs 0.000 description 1
- 206010028417 myasthenia gravis Diseases 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- DDBREPKUVSBGFI-UHFFFAOYSA-N phenobarbital Chemical compound C=1C=CC=CC=1C1(CC)C(=O)NC(=O)NC1=O DDBREPKUVSBGFI-UHFFFAOYSA-N 0.000 description 1
- 229960002695 phenobarbital Drugs 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 208000037920 primary disease Diseases 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 210000001034 respiratory center Anatomy 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 235000002020 sage Nutrition 0.000 description 1
- 235000015598 salt intake Nutrition 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- 238000010025 steaming Methods 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 206010043554 thrombocytopenia Diseases 0.000 description 1
- 201000005060 thrombophlebitis Diseases 0.000 description 1
- CYHOMWAPJJPNMW-JIGDXULJSA-N tropine Chemical compound C1[C@@H](O)C[C@H]2CC[C@@H]1N2C CYHOMWAPJJPNMW-JIGDXULJSA-N 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
年龄(岁) | 26~35 | 21~30 | 31~40 | 41~55 |
例数 | 13 | 191 | 155 | 7 |
百分比 | 3.6% | 52.2% | 42.3% | 1.9% |
疗效 | 治愈 | 好转 | 无效 |
例数 | 365 | 1 | 无 |
百分比 | 99.7% | 0.3% | 无 |
治疗天数 | 3~6 | 7~10 | 11~14 | 15~27 |
例数 | 13 | 215 | 132 | 6 |
百分比 | 3.6% | 58.7% | 36.1% | 1.6% |
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210270923XA CN102784302B (zh) | 2012-08-01 | 2012-08-01 | 一种治疗肾阴亏虚型失眠的中药制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210270923XA CN102784302B (zh) | 2012-08-01 | 2012-08-01 | 一种治疗肾阴亏虚型失眠的中药制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102784302A true CN102784302A (zh) | 2012-11-21 |
CN102784302B CN102784302B (zh) | 2013-11-13 |
Family
ID=47150020
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210270923XA Expired - Fee Related CN102784302B (zh) | 2012-08-01 | 2012-08-01 | 一种治疗肾阴亏虚型失眠的中药制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102784302B (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103110894A (zh) * | 2013-02-14 | 2013-05-22 | 张华� | 一种治疗肾阴亏虚型胁痛的中药制备方法 |
CN105233009A (zh) * | 2015-11-12 | 2016-01-13 | 谭晓燕 | 一种预防治疗失眠多梦症的中药口服液 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1806840A (zh) * | 2005-01-21 | 2006-07-26 | 中国科学院上海药物研究所 | 一种中药复方制剂及其制备方法 |
CN102198258A (zh) * | 2011-05-05 | 2011-09-28 | 苏士峥 | 一种治疗肾阴亏虚型中耳炎的中药制备方法 |
-
2012
- 2012-08-01 CN CN201210270923XA patent/CN102784302B/zh not_active Expired - Fee Related
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1806840A (zh) * | 2005-01-21 | 2006-07-26 | 中国科学院上海药物研究所 | 一种中药复方制剂及其制备方法 |
CN102198258A (zh) * | 2011-05-05 | 2011-09-28 | 苏士峥 | 一种治疗肾阴亏虚型中耳炎的中药制备方法 |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103110894A (zh) * | 2013-02-14 | 2013-05-22 | 张华� | 一种治疗肾阴亏虚型胁痛的中药制备方法 |
CN103110894B (zh) * | 2013-02-14 | 2014-04-16 | 张治国 | 一种治疗肾阴亏虚型胁痛的中药制备方法 |
CN105233009A (zh) * | 2015-11-12 | 2016-01-13 | 谭晓燕 | 一种预防治疗失眠多梦症的中药口服液 |
Also Published As
Publication number | Publication date |
---|---|
CN102784302B (zh) | 2013-11-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102813792B (zh) | 一种治疗痰火扰心型失眠的中药制备方法 | |
CN102784319B (zh) | 一种治疗气阴两虚型失眠的中药制备方法 | |
CN102813831B (zh) | 一种治疗阴虚火旺型失眠的中药制备方法 | |
CN102784358B (zh) | 一种治疗肝郁型失眠的中药制备方法 | |
CN102784372B (zh) | 一种治疗脾虚型失眠的中药制备方法 | |
CN102784302B (zh) | 一种治疗肾阴亏虚型失眠的中药制备方法 | |
CN102784279B (zh) | 一种治疗便秘型失眠的中药制备方法 | |
CN102813797A (zh) | 一种治疗酗酒型失眠的中药制备方法 | |
CN102793863A (zh) | 一种治疗眼底充血型失眠的中药制备方法 | |
CN102813821B (zh) | 一种治疗胃热型失眠的中药制备方法 | |
CN102805812B (zh) | 一种治疗嗜食大蒜型失眠的中药制备方法 | |
CN102784357B (zh) | 一种治疗嗜饮浓茶型失眠的中药制备方法 | |
CN102805813B (zh) | 一种治疗嗜食辣椒型失眠的中药制备方法 | |
CN102813879B (zh) | 一种治疗瘀血型不寐的中药制备方法 | |
CN102784356B (zh) | 一种治疗疼痛型失眠的中药制备方法 | |
CN102813820B (zh) | 一种治疗心肾不交型失眠的中药制备方法 | |
CN102805801B (zh) | 一种治疗吸烟型失眠的中药制备方法 | |
CN102784298B (zh) | 一种治疗嗜食芥末型失眠的中药制备方法 | |
CN102805784B (zh) | 一种治疗搔痒型失眠的中药制备方法 | |
CN102784303B (zh) | 一种治疗夜间汗出型失眠的中药制备方法 | |
CN102784236B (zh) | 一种治疗恼怒型失眠的中药制备方法 | |
CN102784373B (zh) | 一种治疗营养不良型失眠的中药制备方法 | |
CN102784349B (zh) | 一种治疗过食油腻型失眠的中药制备方法 | |
CN102784326B (zh) | 一种治疗溲赤型失眠的中药制备方法 | |
CN102793901B (zh) | 一种治疗腹胀型失眠的中药制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: DOU AIXIA Free format text: FORMER OWNER: MA NIANFANG Effective date: 20131010 |
|
C41 | Transfer of patent application or patent right or utility model | ||
C53 | Correction of patent of invention or patent application | ||
CB03 | Change of inventor or designer information |
Inventor after: Dou Aixia Inventor after: Liu Jun Inventor before: Ma Nianfang |
|
COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: MA NIANFANG TO: DOU AIXIA LIU JUN Free format text: CORRECT: ADDRESS; FROM: 250013 JINAN, SHANDONG PROVINCE TO: 272200 JINING, SHANDONG PROVINCE |
|
TA01 | Transfer of patent application right |
Effective date of registration: 20131010 Address after: 272200 Jinxiang County People's Hospital, Shandong, Jining Applicant after: Dou Aixia Address before: 46 Shandong Chest Hospital, Lixia mountain road, Lixia District, Shandong, Ji'nan 250013, China Applicant before: Ma Nianfang |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20131113 Termination date: 20140801 |
|
EXPY | Termination of patent right or utility model |